Wczytywanie spółki
Just reported
From Mckesson's results release of 4 listopada 2026; its quarterly report has since been filed.
Actual
110,96B USD
+7,6% y/y
+5,3% q/q
Guided
—
No guide given
Actual
10,44 USD
+17% y/y
+103% q/q
Guided
—
No guide given
EPS, adjusted: 11,68 USD
Actual
1,6B USD
+14% y/y
+22% q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Mckesson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
All 11 graded companies in its industryRose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 paź 2026CAGraded C, now AUdziały w przychodach to szacunki za FY2026 ended 2026-03-31, a nie dane z raportu złożonego do regulatora.
Prescription-drug distribution
Wholesale supply and delivery of branded, generic, specialty, biosimilar, and over-the-counter medicines to pharmacies and health providers.
Pharmacy business services
Financial, operational, clinical, consulting, and technology services for retail, hospital, and other pharmacies.
Oncology and multispecialty provider services
Specialty-drug distribution, infusion services, direct-to-patient pharmacy services, and support for community oncology and other specialty-care practices.
Prescription access and affordability services
Services that help check insurance coverage, obtain prior authorization, compare prescription prices, support dispensing, and enroll patients in assistance programs.
Biopharmaceutical logistics and distribution
Storage, transport, and distribution services for biopharmaceutical manufacturers, including products requiring temperature-controlled handling.
Medical, surgical, and laboratory supplies
Distribution of branded and McKesson's own medical, surgical, and laboratory products to care providers outside acute-care hospitals.
Pełne sprawozdania finansowe →
McKesson buys medicines from manufacturers and sells and delivers them to pharmacies, hospitals, and other care providers. It also distributes specialty medicines and supports community oncology practices with services, research, and technology. Its prescription services help connect patients, pharmacies, providers, health plans, and drug manufacturers to handle coverage checks, prior authorization, and affordability programs. It also supplies medical, surgical, and laboratory products to care providers outside hospitals.
Zbudowane z własnych raportów spółki Mckesson Corporation składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
McKesson distributes prescription drugs to pharmacies, hospitals, and clinics, with a smaller business selling medical supplies to care providers.
Grade A
Pasek pod ceną pokazuje ocenę w każdym dniu, wyliczoną wyłącznie z dokumentów, które były wtedy już publiczne.
Pokazujemy 2 z 41 kwartałów historii ocen spółki Mckesson Corporation. Pozostałe 39 sięgają do październik 2016.
